Cargando…
Longevity and Clinical Effectiveness of the Humoral and Cellular Responses to SARS-CoV-2 Vaccination in Hemodialysis Patients
Autores principales: | De Vriese, An S., Van Praet, Jens, Reynders, Marijke, Heylen, Line, Viaene, Liesbeth, Caluwé, Rogier, Schoutteten, Melanie, De Bacquer, Dirk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861256/ https://www.ncbi.nlm.nih.gov/pubmed/35224315 http://dx.doi.org/10.1016/j.ekir.2022.02.007 |
Ejemplares similares
-
Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients
por: De Vriese, An S, et al.
Publicado: (2021) -
Immune Senescence Markers Predict the Cellular Immune Response to BNT162b2 Vaccination in Hemodialysis Patients
por: Van Praet, Jens T, et al.
Publicado: (2022) -
In Reply to ‘Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?’
por: De Vriese, An S., et al.
Publicado: (2020) -
IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis
por: De Vriese, An S., et al.
Publicado: (2020) -
The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials
por: Caluwé, Rogier, et al.
Publicado: (2016)